Ryan N Hansen

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi Economic costs of nonmedical use of prescription opioids
    Ryan N Hansen
    Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
    Clin J Pain 27:194-202. 2011
  2. ncbi Electronic prescribing at the point of care: a time-motion study in the primary care setting
    Emily Beth Devine
    Biomedical and Health Informatics, School of Medicine, University of Washington, Seattle, WA
    Health Serv Res 45:152-71. 2010
  3. ncbi The impact of e-prescribing on prescriber and staff time in ambulatory care clinics: a time motion study
    William Hollingworth
    Department of Radiology, University of Washington, 325 Ninth Avenue, Seattle, WA 98104 2499, USA
    J Am Med Inform Assoc 14:722-30. 2007
  4. ncbi The impact of computerized provider order entry on medication errors in a multispecialty group practice
    Emily Beth Devine
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, Washington 98195 7630, USA
    J Am Med Inform Assoc 17:78-84. 2010
  5. ncbi Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States
    Josh J Carlson
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington Electronic address
    Clin Ther 35:414-24. 2013
  6. ncbi Comparative effectiveness research in the United States: a progress report
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, 1959 NE Pacific Ave, Seattle, WA 98195 7630, USA
    J Med Econ 16:295-7. 2013
  7. ncbi Characterization of prescribing errors in an internal medicine clinic
    Emily Beth Devine
    Department of Pharmacy, University of Washington UW, Seattle, WA 98195 7630, USA
    Am J Health Syst Pharm 64:1062-70. 2007
  8. ncbi Association between antiepileptic drug switching and epilepsy-related events
    Ryan N Hansen
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, 1959 NE Pacific Avenue, Seattle, WA 98195, USA
    Epilepsy Behav 15:481-5. 2009

Collaborators

Detail Information

Publications8

  1. ncbi Economic costs of nonmedical use of prescription opioids
    Ryan N Hansen
    Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
    Clin J Pain 27:194-202. 2011
    ....
  2. ncbi Electronic prescribing at the point of care: a time-motion study in the primary care setting
    Emily Beth Devine
    Biomedical and Health Informatics, School of Medicine, University of Washington, Seattle, WA
    Health Serv Res 45:152-71. 2010
    ..Two primary aims were to compare prescribing time between (1) handwritten and electronic (e-) prescriptions and (2) e-prescriptions using differing hardware configurations...
  3. ncbi The impact of e-prescribing on prescriber and staff time in ambulatory care clinics: a time motion study
    William Hollingworth
    Department of Radiology, University of Washington, 325 Ninth Avenue, Seattle, WA 98104 2499, USA
    J Am Med Inform Assoc 14:722-30. 2007
    ..4 minutes/hour; 0.0, 10.7 CI). E-prescribing was not associated with an increase in combined computer and writing time for prescribers. If carefully implemented, e-prescribing will not greatly disrupt workflow...
  4. ncbi The impact of computerized provider order entry on medication errors in a multispecialty group practice
    Emily Beth Devine
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, Washington 98195 7630, USA
    J Am Med Inform Assoc 17:78-84. 2010
    ..The objective was to evaluate the effect of a basic, ambulatory CPOE system on medication errors and associated ADEs...
  5. ncbi Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States
    Josh J Carlson
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington Electronic address
    Clin Ther 35:414-24. 2013
    ..However, the economic impact of onabotulinumtoxinA treatment for UI due to NDO in the United States remains unknown...
  6. ncbi Comparative effectiveness research in the United States: a progress report
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, 1959 NE Pacific Ave, Seattle, WA 98195 7630, USA
    J Med Econ 16:295-7. 2013
    ..Expectations for CER are high and public and private investments are sizeable. This paper discussions the evolution of CER in the US and gives a brief report on its progress and challenges...
  7. ncbi Characterization of prescribing errors in an internal medicine clinic
    Emily Beth Devine
    Department of Pharmacy, University of Washington UW, Seattle, WA 98195 7630, USA
    Am J Health Syst Pharm 64:1062-70. 2007
    ....
  8. ncbi Association between antiepileptic drug switching and epilepsy-related events
    Ryan N Hansen
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, 1959 NE Pacific Avenue, Seattle, WA 98195, USA
    Epilepsy Behav 15:481-5. 2009
    ..These findings suggest that care should be taken when considering a switch between A-rated AEDs in patients with epilepsy...